{
    "2018-04-17": [
        [
            {
                "time": "2018-04-15",
                "original_text": "AbbVie Inc. Is a Clear Value Play in Biotech Stocks",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "value play",
                        "biotech"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-16",
                "original_text": "Top Analyst Reports for AbbVie, Berkshire & PepsiCo",
                "features": {
                    "keywords": [
                        "analyst reports",
                        "AbbVie",
                        "Berkshire",
                        "PepsiCo"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "consumer goods"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-17",
                "original_text": "7 Stock Picks With Giant Upside: Goldman",
                "features": {
                    "keywords": [
                        "stock picks",
                        "Goldman",
                        "upside"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-18",
                "original_text": "J&J (JNJ) Tops Q1 Earnings Estimates, Raises Sales Guidance",
                "features": {
                    "keywords": [
                        "J&J",
                        "Q1 earnings",
                        "sales guidance"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-19",
                "original_text": "5 Drug Stocks Poised to Surpass on Earnings This Quarter",
                "features": {
                    "keywords": [
                        "drug stocks",
                        "earnings",
                        "quarter"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "Shire Sells Oncology Unit Ahead of Takeda's Potential Offer",
                "features": {
                    "keywords": [
                        "Shire",
                        "oncology unit",
                        "Takeda",
                        "offer"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-21",
                "original_text": "Novartis’s 1Q18: Analysts Expect Revenue Growth",
                "features": {
                    "keywords": [
                        "Novartis",
                        "revenue growth",
                        "analysts"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-22",
                "original_text": "Updates on AbbVie’s AndroGel, Lupron, and Kaletra",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "AndroGel",
                        "Lupron",
                        "Kaletra"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-23",
                "original_text": "Risankizumab Could Be AbbVie’s Long-Term Growth Driver",
                "features": {
                    "keywords": [
                        "Risankizumab",
                        "AbbVie",
                        "growth driver"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-24",
                "original_text": "AbbVie’s Imbruvica in 4Q17 and Fiscal 2017",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Imbruvica",
                        "4Q17",
                        "fiscal 2017"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}